AstraZeneca Oncology R&D Head On China Biotech Innovation

Looking Again At New Deals

 
• By Dexter Jie Yan
  
China drug R&D
China's biotech innovation has attracted AstraZeneca back to deal-making in the country • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia